Abstract：
OBJECTIVE: This aimed to develop a blueprint for an effective community pharmacy Hepatitis C virus (HCV) testing service by producing a consensus statement.
METHODS: This was a modified Delphi process.
METHODS: We recruited a heterogenous panel of experts (who had been involved in the setup or delivery of a community pharmacy HCV testing service) by purposive and chain referral methods. We had three rounds of a modified Delphi process. The first was a series of questions with free text responses and was analysed using thematic analysis, and the second and third were statements for the respondents to rate using a 7-point Likert scale. Consensus was predefined in a published protocol, and the results were reviewed by a public and patient involvement panel before the statement was finalised.
RESULTS: We had 24 participants, including community and hospital-based pharmacists, local pharmaceutical committee members, charity representatives (Hepatitis C Trust), local clinical service lead, nurse specialists and doctors. The response rate of the first, second and third rounds were 100%, 96% and 88%, respectively. After the third round, we had 60 statements that reached consensus. We discussed the accepted statements with a patient and public involvement group. We used these statements to produce the I-COPTIC statement and a graphical summary.
CONCLUSIONS: We developed a blueprint for the design of a gold standard community pharmacy HCV testing service. We believe this will support the successful implementation of community pharmacy testing for HCV. Community pharmacy testing is an important service to help achieve and maintain HCV elimination.
METHODS: This was a modified Delphi process.
METHODS: We recruited a heterogenous panel of experts (who had been involved in the setup or delivery of a community pharmacy HCV testing service) by purposive and chain referral methods. We had three rounds of a modified Delphi process. The first was a series of questions with free text responses and was analysed using thematic analysis, and the second and third were statements for the respondents to rate using a 7-point Likert scale. Consensus was predefined in a published protocol, and the results were reviewed by a public and patient involvement panel before the statement was finalised.
RESULTS: We had 24 participants, including community and hospital-based pharmacists, local pharmaceutical committee members, charity representatives (Hepatitis C Trust), local clinical service lead, nurse specialists and doctors. The response rate of the first, second and third rounds were 100%, 96% and 88%, respectively. After the third round, we had 60 statements that reached consensus. We discussed the accepted statements with a patient and public involvement group. We used these statements to produce the I-COPTIC statement and a graphical summary.
CONCLUSIONS: We developed a blueprint for the design of a gold standard community pharmacy HCV testing service. We believe this will support the successful implementation of community pharmacy testing for HCV. Community pharmacy testing is an important service to help achieve and maintain HCV elimination.
摘要：
目的：通过达成共识声明，为有效的社区药房丙型肝炎病毒（HCV）检测服务制定蓝图。
方法：这是一个改进的Delphi过程。
方法：我们通过有目的和连锁转诊方法招募了一个异质专家小组（参与了社区药房HCV检测服务的设置或交付）。我们进行了三轮修改的Delphi过程。首先是一系列带有自由文本回答的问题，并使用主题分析进行了分析，第二个和第三个是受访者使用7分Likert量表进行评分的陈述。共识是在已发布的协议中预定义的，结果在声明定稿前由公众和患者参与小组审查.
结果：我们有24名参与者，包括社区和医院的药剂师，当地药物委员会成员，慈善代表（丙型肝炎信托），当地临床服务负责人，护士专家和医生。第一个的反应率，第二轮和第三轮是100%，96%和88%，分别。第三轮之后,我们有60份声明达成共识。我们与患者和公众参与小组讨论了公认的陈述。我们使用这些语句来生成I-COPTIC语句和图形摘要。
结论：我们为黄金标准社区药房HCV检测服务的设计制定了蓝图。我们相信这将支持成功实施社区药房HCV检测。社区药房检测是帮助实现和维持HCV消除的重要服务。
方法：这是一个改进的Delphi过程。
方法：我们通过有目的和连锁转诊方法招募了一个异质专家小组（参与了社区药房HCV检测服务的设置或交付）。我们进行了三轮修改的Delphi过程。首先是一系列带有自由文本回答的问题，并使用主题分析进行了分析，第二个和第三个是受访者使用7分Likert量表进行评分的陈述。共识是在已发布的协议中预定义的，结果在声明定稿前由公众和患者参与小组审查.
结果：我们有24名参与者，包括社区和医院的药剂师，当地药物委员会成员，慈善代表（丙型肝炎信托），当地临床服务负责人，护士专家和医生。第一个的反应率，第二轮和第三轮是100%，96%和88%，分别。第三轮之后,我们有60份声明达成共识。我们与患者和公众参与小组讨论了公认的陈述。我们使用这些语句来生成I-COPTIC语句和图形摘要。
结论：我们为黄金标准社区药房HCV检测服务的设计制定了蓝图。我们相信这将支持成功实施社区药房HCV检测。社区药房检测是帮助实现和维持HCV消除的重要服务。
